Reuters -- Shire, Britain’s third largest drugmaker, forecast a return to revenue and earnings growth in 2010 after reporting better than expected results for last year, helped by reduced drug rebates in the United States.
Reuters -- Shire, Britain’s third largest drugmaker, forecast a return to revenue and earnings growth in 2010 after reporting better than expected results for last year, helped by reduced drug rebates in the United States.
